stockrow
Friday 6 November 2026
Export DFTX’s income statement to Excel — free account
Definium Therapeutics, Inc.
DFTX Healthcare Biotechnology
- EPS
- −188.0%
- Free cash flow
- −78.3%
- Total debt
- −11.5%
Quarter to June 2026, against a year earlier
33.27
2.91
+9.58%
Follow DFTX
Alert me
Definium Therapeutics, Inc. (DFTX) Shares outstanding
Definium Therapeutics, Inc.'s shares outstanding at the end of fiscal 2025 was $89.3M, up 26.8% from $70.5M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $110.7M. Over the past ten years it has ranged from $252.8K (fiscal 2017) to $89.3M (fiscal 2025) — the current reading is the highest in ten years. Definium Therapeutics, Inc. ranks 127th of 600 Biotechnology companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $89.3M | 26.78% |
| FY2024 | $70.5M | 79.94% |
| FY2023 | $39.2M | 26.90% |
| FY2022 | $30.9M | 12.71% |
| FY2021 | $27.4M | 54.18% |
| FY2020 | $17.8M | 159.06% |
| FY2019 | $6.9M | 2,093.41% |
| FY2018 | $312.5K | 23.62% |
| FY2017 | $252.8K | (79.04%) |
| FY2016 | $1.2M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $110.7M | 1.74% |
| Mar 2026 | $108.8M | 21.79% |
| Dec 2025 | $89.3M | 4.01% |
| Sep 2025 | $85.9M | 0.63% |
| 24 more quarters | Free account |
Against its own ten years
Low $252.8K
High $89.3M
Ten-year median
$22.6M
Current reading's percentile
100
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| ERAS Erasca, Inc. compare | $311.3M |
| ABCL AbCellera Biologics Inc. compare | $305.6M |
| RLAY Relay Therapeutics, Inc. compare | $219.2M |
| LEGN Legend Biotech Corporation Sponsored ADR compare | $193.8M |
| ACAD ACADIA Pharmaceuticals Inc. compare | $175.5M |
| EWTX Edgewise Therapeutics, Inc. compare | $120.9M |
| DFTX Definium Therapeutics, Inc. | $110.7M |
| XENE Xenon Pharmaceuticals Inc. compare | $99.6M |
| DNTH Dianthus Therapeutics, Inc. compare | $57.3M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item